You are here: vision-research.eu » Vision Research » Vision in the European Focus » Vision in the European Focus - Details

XOVA eXcellence in Ophthalmology Vision Awards applications are now open!

Novartis Ophthalmology - Reimagining the treatment and prevention of visual impairment and blindness. €500,000 is available to fund a minimum of 10 awards for up to €50,000 each.

The XOVA Vision Awards program aims to help reduce the burden of blindness around the world by providing funding for non-profit initiatives that strive to make improvements within the field of eye care.

The eXcellence in Ophthalmology Vision Award (XOVA) is an award program that aims to support initiatives that help deliver sustainable, improved eye care to reduce the burden of blindness around the world. Patient advocacy groups, non-governmental organizations (NGOs), ophthalmologists, optometrists, specialist eye care nurses and allied eye healthcare professionals (including those in training) can all apply, provided the application is made on behalf of an academic institution or organization. Project outcomes should be specific, measurable, achievable, relevant and time-bound. Please note, XOVA is not intended to provide funding for basic research or clinical trials and projects that have commenced prior to application submission will not be considered.

Applications must be made on behalf of an academic institution or organization that endorses the application. An academic institution, such as a university, is one example of a suitable endorsing institution, but other types of organizations also qualify.

This is required because Novartis Pharma AG need to execute a sponsorship agreement with the endorsing institution or organization prior to the release of any funding. It is not possible to fund, or execute an agreement with, an individual person.

Empowering eye care specialists to transform communities since 2010

44 projects funded to 201927 benefiting countries/regions in

  • ASIA: Bangladesh, Cambodia, China, Federated States of Micronesia, India, Indonesia, Laos, Myanmar, Nepal, Papua New Guinea, Vietnam,
  • AFRICA: Guinea-Bissau, Ghana, Kenya, Nigeria, Ethiopia, Republic of Congo, Rwanda, South Africa, Subsahara, Sudan, Tanzania, Uganda, Zimbabwe,
  • THE AMERICAS: Brazil, Guyana, Mexico

For further details, visit www.xova.novartis.com or contact the XOVA team at XOVA.program[at]novartis.com

Applications open until 31 January 2021

Vision in the European Focus Vision Research and Ophthalmology

Back